Based on the provided trial data, I cannot identify specific medications or therapies to list, as the source data does not contain information about the actual medications used in the trial. While the title mentions antibiotics for respiratory tract infections, it does not specify which antibiotics are being studied.

To provide accurate medication descriptions, I would need specific information about which antibiotics or other therapies are being evaluated in this STORM Study focused on respiratory tract infections in primary care.

Acute Lower Respiratory Tract Infection – A condition affecting the airways below the larynx, including the bronchi and lungs. It typically develops as inflammation of the airways, causing symptoms such as cough, shortness of breath, and possible production of mucus. The infection can cause the airways to become swollen and inflamed, making breathing more difficult. The condition usually develops over several days.

Acute Rhinosinusitis – An inflammatory condition affecting the nasal passages and sinuses, usually developing after a viral upper respiratory infection. It causes swelling in the sinuses and nasal passages, leading to symptoms such as nasal congestion, facial pain or pressure, and reduced sense of smell. The condition can cause mucus buildup in the sinus cavities. Symptoms typically develop within a few days and may include headache and facial discomfort.